Lv1
89 积分 2024-08-19 加入
Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial
14天前
已完结
A420 The Long Term (15 year) Impact of Bariatric Surgery on Conversion from Pre-Diabetes to Type II Diabetes Mellitus
14天前
已关闭
Diabetes remission and diabetic complications of bariatric surgery vs. medical management in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
14天前
已关闭
2型糖尿病患者体重管理的研究进展与思考
1个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
1个月前
已完结
Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
1个月前
已完结
Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
1个月前
已完结
Dozens of new obesity drugs are coming: these are the ones to watch
2个月前
已完结
The expanding landscape of GLP-1 medicines
2个月前
已完结
Peptide complex containing GLP-1 exhibited long-acting properties in the treatment of type 2 diabetes
2个月前
已关闭
皖公网安备34019202002308
